Melanoma Treatment: Comparing Immune Therapies

We are studying two different immune therapy treatments for patients with resectable stage III melanoma. Our goal is to see which treatment may help improve survival without disease progression.

≤5 visitsConfirmation phase (III)No PlaceboStandard MedicinesInjectionDermatologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Opdivo
Opdivo is a cancer medicine that helps the immune system find and fight tumor cells.
Yervoy
Yervoy is a cancer medicine that helps the immune system find and attack melanoma and some other types of tumors.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ipilimumab
Ipilimumab is a substance that helps the immune system attack cancer by blocking a protein that keeps immune cells from working.
Nivolumab
Nivolumab is a substance that helps the immune system recognize and attack certain cancers.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Opdualag

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Sahlgrenska University Hospital-Vaestra Goetalandsregionen
Oncology
Göteborg, Sweden
Region Skane Skanes Universitetssjukhus
Oncology
Lund, Sweden
Karolinska University Hospital
Head, Neck, Lung and Skin Cancer
Solna, Sweden
Sponsor: Karolinska University Hospital
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.